Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-001850
Filing Date
2024-02-27
Accepted
2024-02-27 16:33:25
Documents
102
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptgx-20231231x10k.htm   iXBRL 10-K 2566460
2 EX-4.2 ptgx-20231231xex4d2.htm EX-4.2 19614
3 EX-21.1 ptgx-20231231xex21d1.htm EX-21.1 3485
4 EX-23.1 ptgx-20231231xex23d1.htm EX-23.1 3937
5 EX-31.1 ptgx-20231231xex31d1.htm EX-31.1 11394
6 EX-31.2 ptgx-20231231xex31d2.htm EX-31.2 11622
7 EX-32.1 ptgx-20231231xex32d1.htm EX-32.1 10810
8 EX-97.1 ptgx-20231231xex97d1.htm EX-97.1 11835
9 GRAPHIC ptgx-20231231x10k006.jpg GRAPHIC 104902
10 GRAPHIC ptgx-20231231x10k007.jpg GRAPHIC 84720
11 GRAPHIC ptgx-20231231x10k008.jpg GRAPHIC 109977
12 GRAPHIC ptgx-20231231x10k009.jpg GRAPHIC 94808
  Complete submission text file 0001558370-24-001850.txt   11791694

Data Files

Seq Description Document Type Size
13 EX-101.SCH ptgx-20231231.xsd EX-101.SCH 73055
14 EX-101.CAL ptgx-20231231_cal.xml EX-101.CAL 66469
15 EX-101.DEF ptgx-20231231_def.xml EX-101.DEF 296889
16 EX-101.LAB ptgx-20231231_lab.xml EX-101.LAB 574998
17 EX-101.PRE ptgx-20231231_pre.xml EX-101.PRE 504125
104 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20231231x10k_htm.xml XML 1934761
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37852 | Film No.: 24687482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)